ACC, SVS join forces on single vascular registry

Jun 30, 2020 Re-posted from the July 2020 issue of Vascular Specialist

BY BETH BALES

Effective January 2021, the ACC’S NCDR will collaborate with the SVS Vascular Quality Initiative (VQI) to support and steer a single vascular registry. SVS will operate the registry, creating a cobranded VQI program that will be a unique, comprehensive resource for measuring and improving the care provided to a growing population of patients with vascular diseases.

“The ACC NCDR and the SVS VQI are the two leading clinical registries in the peripheral vascular space. A single registry combines the resources and expertise from both organizations. We are merging the best elements of both registries to create the premier vascular clinical registry,” said VQI medical director Jens Eldrup-Jorgensen, MD. “We look forward to working with the ACC and other medical society collaborators that will allow us to enrich the VQI and improve the care of vascular patients.”

Originating as the CARE Registry in 2006 and expanding scope in 2014 to include lower extremity, vascular catheter-based interventions, the ACC’s Peripheral Vascular Intervention (PVI) Registry assesses the prevalence, demographics, management and outcomes of patients undergoing percutaneous treatment for peripheral vascular disease. To date, the PVI Registry includes patient data from more than 200 institutions.

VQI began in 2010 as an expansion of the Vascular Study Group of New England, which originated in 2003. More than 675 centers participate in VQI, which has 13 procedural-based registries encompassing the treatment of arterial and venous disease as well as a disease-based registry collecting data on the medical management of aneurysms, carotid stenosis and lower extremity arterial occlusive disease.

“The ACC is committed to working with all of our partners in cardiovascular care to create a cohesive source of vascular disease data,” said ACC president Athena Poppas, MD. “In combining our registry with that of SVS, we are providing uniform, actionable information for physicians and health systems.”

The new registry collaboration will provide greater opportunities to evaluate new and emerging technologies, pharmacologic therapies, and medical and lifestyle management. It will also provide a rich source of data for academicians, the FDA and industry looking to answer scientific questions about patient characteristics and outcomes and the use and effectiveness of different treatments.

“The SVS is proud of its history of working with other medical societies, government agencies and industry when developing quality improvement programs to improve the quality of vascular care,” said SVS president Ronald Dalman, MD. “Working with the ACC on this initiative is another example of how collaboration and inclusion can improve the services we offer to caregivers and our patients.”

Tags
Vascular Specialist

Related Articles

Education and Representation at the Core of Inclusivity Efforts for DEI Committe

This article was published in the October issue of Vascular Specialist.

The Society for Vascular Surgery’s (SVS) Diversity, Equity, and Inclusion (DEI) Committee continues to make strides in advancing inclusivity within the organization, with several projects underway to address both ongoing challenges and new opportunities.

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.